(Q44472847)

English

The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction

scientific article

Statements

The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction (English)
Mina Monfared
Kieran Clarke
Stefan Neubauer
632-637

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit